The Idylla™ KRAS Mutation Test, performed on the Biocartis Idylla™ system, is a fully automated, real-time PCR,  in vitro diagnostic test for the qualitative detection of

21 relevant KRAS mutations: 7 mutations in codons 12 and 13 (exon 2), 9 mutations in codons 59 and 61 (exon 3) and 5 mutations in codons 117 and 146 (exon 4).

The KRAS mutation test allows detection of KRAS mutations directly from formalin-fixed paraffin-embedded (FFPE) tissue sections in approximately 2 hours. 

Cases negative for KRAS mutations will be reflex tested for NRAS/BRAF mutations, also on the Idylla platform.

To order, please complete Austin Molecular Solid Tumour Test Request Form indicating the test required and the biopsy number and date of collection of the sample you wish to be tested.

Note: To be bulk billable please get the patient to sign the Medicare assignment, or if they are unable to do so, please sign on their behalf.